Imanova Announces 2014 IMPETus Awards For Early Molecular Imaging Research

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

London, February 27, 2014: Imanova Limited, the Centre for Imaging Sciences in London, has announced that five researchers from Imperial College London, King’s College London and UCL are to receive IMPETus awards. The awards are designed to both encourage the wider use of imaging and to enable researchers new to the area to gather the data required for its inclusion in full grant applications. Following the success of a pilot PET programme in 2012, IMPETus has now been officially launched and includes awards to scientists investigating not only dementia, depression and neurodegeneration, but also obesity and autism.

The researchers selected include Dr Grainne McAlonan, Dr Alessandro Colasanti and Dr Marios Politis of King’s College London, Dr Paul Edison of Imperial College London and Dr Jonathan Rohrer of UCL. The candidates’ research will include projects investigating the influence of obesity on neuroinflammation in Alzhiemer's disease, mutations in the tau gene in frontotemporal dementia and brain GABA-A receptors in gene deletion and duplication syndromes linked to autism spectrum. The researchers were awarded the grants as a result of the outstanding scientific merit of their work and for the innovative use of existing tracers in novel research areas. The studies will be carried out at Imanova’s world class facilities in London.

“We are delighted with the high calibre of experimental medicine studies for this year’s PET programme at Imanova and look forward to supporting this work,” announced Roger Gunn, CSO of Imanova Limited. “We believe that by providing access to our world-class imaging facilities, we can create an environment for sharing ideas, resources and expertise in imaging, whilst training and developing the next generation of imaging scientists and practitioners.”

The pilot studies from the initial round in 2012 can be found in Imanova’s annual report: http://www.imanova.co.uk/company/annual-review/

You can read more about the pilot IMPETus programme here

About Imanova

Imanova Limited – the centre of excellence for imaging sciences, is a unique concept established to drive creativity and innovation in imaging sciences. Imanova is the former GSK Clinical Imaging Centre, which is now an independent company owned by a consortium of three world-class London universities (Imperial College, King’s College and University College London) and the UK’s Medical Research Council. Imanova's objective is to build on the reputation of the Clinical Imaging Centre as a leading centre for the application of imaging technology, become the international ‘partner of choice’ for pharma and biotech in the application of imaging to drug development, and to operate to the highest standards of quality and compliance as defined by leading external regulatory bodies. Imanova is located at Imperial College London’s Hammersmith Hospital campus.

Help employers find you! Check out all the jobs and post your resume.

Back to news